T1	Participants 139 231	patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA)
T2	Participants 715 738	252 of the 331 patients
T3	Participants 772 829	211 had lung cancer. Breast cancer patients were excluded